Clin2
NCT05281952Possibly a fitRecruiting

Tested ways to treat severe nosebleeds after failed packing

Epistaxis

Part of Ear, nose & throat, Lungs & breathing clinical trials.

This study looks at different management strategies for severe nosebleeds when the initial packing method has not worked for over 48 hours. It also measures the cost/benefit of these approaches to help improve care.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
180 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older with severe nosebleeds that did not stop after double packing for more than 48 hours
  • You are covered by France’s social security system (or are a beneficiary)
  • You are willing to be assigned by chance (randomization) to one of the management strategies
  • You can give free, informed written consent before any study tests
  • Your nosebleed is not caused by facial or recent surgical injury, and not by a cancer-related tumor
  • You have not had prior procedures to block or stop bleeding (ligation or embolization) for this problem

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06657053Not yet recruiting
Nasal packing to stop nosebleeds in the emergency room

This study tests whether a special nasal packing (a soft material placed in the nose) stops nosebleeds better than the usual treatment. It may help people who come to the emergency room with a nosebleed that won't stop.

La Tronche, ISERE
NCT07511192Not yet recruiting· Phase 4
Plant-based ointment for recurring nosebleeds

This trial tests whether a plant-based ointment (B-sitosterol) applied inside the nose works better than a standard petroleum jelly to reduce recurring nosebleeds. If you have frequent nosebleeds without an obvious cause, this treatment might help you.

NCT07667413Not yet recruiting· Phase 1
Topical gel for nosebleeds in hereditary hemorrhagic telangiectasia (HHT)

This trial tests a new topical gel (TOR-582) applied inside the nose to reduce nosebleeds in people with HHT. It may help by targeting the abnormal blood vessels that cause frequent bleeding.

New York, New York
NCT06651840Not yet recruiting
Comparison of two procedures to stop frequent nosebleeds in children

This study compares two ways to stop frequent nosebleeds in children who have not been helped by simpler treatments. Children will get one of two minor procedures to seal the tiny blood vessel in the nose that keeps bleeding, and the study will see which works better and is safer.

NCT07421622Not yet recruiting
Comparing nose packing to numbing injection for stubborn nosebleeds

This study compares two treatments for stubborn nosebleeds: packing the nose with gauze or a numbing injection in the roof of the mouth to stop bleeding. It aims to see which method works better for people whose nosebleed won't stop with simple pressure.

NCT06997796Recruiting· Phase 1/Phase 2
Treating Nosebleeds in the ER with Powder Tranexamic Acid

This trial tests whether a powder form of tranexamic acid can stop nosebleeds faster in people who come to the emergency room with active bleeding. It may offer a new option if standard treatments don't work well.

Peterborough, Ontario

Hear when a new Epistaxis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.